Penumbra (PEN) Change in Acquisitions & Divestments (2014 - 2026)
Penumbra (PEN) reported Change in Acquisitions & Divestments of $125.1 million for Q1 2026, up 862.61% year-over-year from $13.0 million in Q1 2025, and up 862.61% quarter-over-quarter from $13.0 million in Q1 2025.
Penumbra (PEN) Change in Acquisitions & Divestments (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Change in Acquisitions & Divestments data on file, last reported at $125.1 million in Q1 2026.
- Change in Acquisitions & Divestments for Q1 2026 came in at $125.1 million, up 862.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $125.1 million (up 24.84% YoY), and the FY2025 annual result was $13.0 million, down 90.05% from the prior year.
- Change in Acquisitions & Divestments climbed to $125.1 million in Q1 2026 per PEN's latest filing, from $13.0 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $125.1 million in Q1 2026 and troughed at -$46.1 million in Q4 2023.
- A 5-year average of $24.4 million and a median of $17.1 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2023 and 2026: Change in Acquisitions & Divestments plunged 477.78% in 2023, then jumped 862.61% in 2026.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at $12.2 million in 2022, then sank by 477.78% to -$46.1 million in 2023, then jumped by 110.42% to $4.8 million in 2024, then soared by 170.83% to $13.0 million in 2025, then jumped by 862.61% to $125.1 million in 2026.
- Business Quant data shows PEN's Change in Acquisitions & Divestments at $125.1 million in Q1 2026, $13.0 million in Q1 2025, and $4.8 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125.14 Mn |
| Mar 31, 2026 | 125.14 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Dec 31, 2024 | 4.80 Mn |
| Dec 31, 2024 | 4.80 Mn |
| Sep 30, 2024 | 42.89 Mn |
| Sep 30, 2024 | 42.89 Mn |
| Jun 30, 2024 | 39.55 Mn |
| Jun 30, 2024 | 39.55 Mn |
| Mar 31, 2024 | 43.38 Mn |
| Mar 31, 2024 | 43.38 Mn |
| Dec 31, 2023 | -46.07 Mn |
| Dec 31, 2023 | -46.07 Mn |
| Sep 30, 2023 | 18.10 Mn |
| Sep 30, 2023 | 18.10 Mn |
| Jun 30, 2023 | 13.37 Mn |
| Jun 30, 2023 | 13.37 Mn |
| Mar 31, 2023 | 14.61 Mn |
| Mar 31, 2023 | 14.61 Mn |